LIVE Public of India  •  Pan-India Citizen Newsroom  •  Verified Reporting
support@publicofindia.in Membership
BREAKING
Submit your story — verified, policy-led, privacy-first publishing Hindi & English news updated every 15 minutes from across India Members get priority review, profile badge & creator dashboard Public of India is a private platform — not a government website Submit your story — verified, policy-led, privacy-first publishing Hindi & English news updated every 15 minutes from across India Members get priority review, profile badge & creator dashboard Public of India is a private platform — not a government website
Home  /  BUSINESS  /  Artelo Reports ART27.13 Matches Semaglutide Wei...
BUSINESS Verified

Artelo Reports ART27.13 Matches Semaglutide Weight Loss In Obesity Model

India 12h ago Source: publicofindia

Artelo Biosciences (ARTL) reported nonclinical data showing ART27.13 reduced body weight by about 20% in obese mice, comparable to semaglutide. Combining ART27.13 with semaglutide produced approximately 40% weight loss, about twice the reduction seen with either treatment alone.

This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.